Xtant Medical Holdings, Inc. (XTNT) Stock Forecast
Data as of Sep 20, 2026Healthcare · Current price $0.33 (-0.61%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
XTNT vs Sector & Market
| Metric | XTNT | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 2 | 8 | 18 |
| Target Upside | +207.7% | +22243.5% | +21.5% |
| P/E Ratio | 15.54 | 3.75 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $95M | $96M | $97M | 2 |
| 2027-12-31 | $104M | $105M | $106M | 2 |
| 2028-12-31 | $114M | $115M | $116M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.01 | $0.01 | $0.01 | 1 |
| 2027-12-31 | $-0.00 | $-0.00 | $-0.00 | 1 |
| 2028-12-31 | $-0.09 | $-0.03 | $0.03 | 2 |
Frequently Asked Questions
What is the analyst consensus for XTNT?
The consensus among 2 analysts covering Xtant Medical Holdings, Inc. (XTNT) is Buy with an average price target of $1.50.
What is the highest price target for XTNT?
The highest analyst price target for XTNT is $1.50.
What is the lowest price target for XTNT?
The lowest analyst price target for XTNT is $1.50.
How many analysts cover XTNT?
2 analysts have issued ratings for Xtant Medical Holdings, Inc. in the past 12 months.
Is XTNT a buy or sell right now?
Based on 2 analyst ratings, XTNT has a consensus rating of Buy (2.00/5) with a +207.7% upside to the consensus target of $1.50.
What are the earnings estimates for XTNT?
Analysts estimate XTNT will report EPS of $0.01 for the period ending 2026-12-31, with revenue estimated at $96M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.